OTCMPPJE
Market cap530kUSD
Dec 27, Last price
0.00USD
1D
-99.00%
1Q
-99.00%
Jan 2017
-99.00%
Name
PPJ Healthcare Enterprises Inc
Chart & Performance
Profile
PPJ Healthcare Enterprises, Inc., through its subsidiaries, provides automated healthcare reimbursement cycle, online health information digital-systems, and practice information management digital-system software to health care providers and general businesses worldwide. The company offers the Automated Biller, a medical billing system that allows physicians to bill their medical insurance claims at the point of service without data entry, coding, or billing personnel. It also provides billing, specialty medical billing, collection, and workers comp lien collection services for health care providers in the areas of pain management, anesthesia and surgery centers practices, and various specialties of medicine. The company was formerly known as PPJ Enterprise and changed its name to PPJ Healthcare Enterprises, Inc. in October 2014. PPJ Healthcare Enterprises, Inc. was founded in 2000 and is headquartered in Reno, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 711 -10.06% | 791 21.86% | 649 112.34% | ||||||
Cost of revenue | 495 | 514 | 379 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 216 | 277 | 270 | ||||||
NOPBT Margin | 30.39% | 35.04% | 41.62% | ||||||
Operating Taxes | (168) | (228) | (237) | ||||||
Tax Rate | |||||||||
NOPAT | 384 | 505 | 507 | ||||||
Net income | 75 -47.06% | 141 0.00% | 141 251.47% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 15,918 | 15,918 | 20,332 | ||||||
BB yield | -963.85% | -1,000.00% | -525.00% | ||||||
Debt | |||||||||
Debt current | 2,593 | 2,671 | 2,797 | ||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 2,544 | 2,264 | 2,150 | ||||||
Cash flow | |||||||||
Cash from operating activities | 2,532 | 3,020 | 13,846 | ||||||
CAPEX | |||||||||
Cash from investing activities | 1,002 | 1,078 | |||||||
Cash from financing activities | 15,954 | 15,973 | 20,437 | ||||||
FCF | 308 | (772) | (3,144) | ||||||
Balance | |||||||||
Cash | 49 | 407 | 646 | ||||||
Long term investments | |||||||||
Excess cash | 14 | 367 | 614 | ||||||
Stockholders' equity | 38,609 | 37,751 | 10,504 | ||||||
Invested Capital | 14,555 | 14,484 | 13,179 | ||||||
ROIC | 2.64% | 3.65% | 4.47% | ||||||
ROCE | 1.48% | 1.87% | 1.96% | ||||||
EV | |||||||||
Common stock shares outstanding | 5,504,836 | 5,305,836 | 4,840,836 | ||||||
Price | 0.00 0.00% | 0.00 -62.50% | 0.00 33.33% | ||||||
Market cap | 1,651 3.75% | 1,592 -58.90% | 3,873 33.33% | ||||||
EV | 9,890 | 9,551 | 11,718 | ||||||
EBITDA | 216 | 277 | 270 | ||||||
EV/EBITDA | 45.78 | 34.48 | 43.40 | ||||||
Interest | |||||||||
Interest/NOPBT |